RSLS | ReShape Lifesciences Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31
Revenue	8.68M	11.24M	13.60M	11.30M	15.09M	606.71K	1.29M	786.66K	292.00K	N/A	N/A	312.00K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	3.13M	4.44M	5.25M	5.04M	5.78M	164.30K	936.39K	431.48K	125.00K	N/A	N/A	232.00K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	5.55M	6.80M	8.35M	6.26M	9.30M	442.41K	350.77K	355.18K	167.00K	N/A	N/A	80.00K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Expenses	20.19M	33.88M	36.10M	18.72M	25.19M	24.98M	31.76M	23.15M	28.03M	25.59M	24.73M	22.63M	25.26M	16.18M	24.21M	36.27M	28.03M	18.12M	11.15M	-3.45M	-1.90M
Selling, General & Admin	17.87M	31.34M	33.58M	15.22M	22.07M	19.26M	25.98M	17.98M	19.89M	14.56M	13.66M	11.96M	8.58M	7.68M	8.63M	8.60M	6.97M	3.76M	2.32M	N/A	N/A
Research & Development	2.31M	2.54M	2.52M	3.50M	3.12M	5.72M	5.78M	5.17M	8.14M	11.03M	11.07M	10.67M	16.67M	8.50M	15.58M	27.67M	21.05M	14.36M	8.83M	N/A	N/A
Other Operating Expenses	N/A	11.00K	23.50M	306.00K	-1.34M	-10.64K	-652.00	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-3.45M	-1.90M
Operating Income	-14.64M	-27.08M	-27.75M	-12.46M	-15.89M	-38.55M	-31.41M	-22.80M	-27.87M	-25.59M	-24.73M	-22.55M	-25.26M	-16.18M	-24.21M	-36.27M	-28.03M	-18.12M	-11.15M	-3.45M	-1.90M
Other Expenses / Income	3.30M	-4.68M	-12.17M	-9.35M	-50.64M	-167.73K	-1.37M	-565.22K	2.37M	-535.73K	-1.05M	-911.14K	-30.12K	-1.17M	-7.72M	-21.86K	-456.88K	5.59K	8.36K	N/A	N/A
Before Tax Income	-11.34M	-46.59M	-62.04M	-21.81M	-75.10M	-38.71M	-36.13M	-23.36M	-25.50M	-26.13M	-25.78M	-23.46M	-25.29M	-17.35M	-31.93M	-36.29M	-28.48M	-18.12M	-11.14M	N/A	N/A
Income Tax Expenses	52.00K	-380.00K	-106.00K	-181.00K	-893.00K	-3.45M	-2.31M	3.96M	-2.56M	347.10K	872.37K	-226.99K	740.74K	794.24K	7.29M	1.60M	549.15K	-431.34K	62.91K	3.45M	1.90M
Net Income	-11.39M	-46.21M	-61.93M	-21.63M	-74.21M	-81.15M	-33.82M	-23.36M	-25.50M	-26.13M	-25.78M	-23.46M	-26.00M	-17.35M	-31.93M	-37.87M	-28.58M	-17.69M	-11.22M	-3.45M	-1.90M
Interest Expenses	N/A	113.00K	832.00K	2.05M	451.00K	12.38K	3.87K	4.10M	939.18K	530.22K	932.36K	901.84K	722.86K	1.26M	4.10M	2.68M	1.65M	710.11K	181.15K	N/A	N/A
Basic Shares Outstanding	102.70K	7.32K	3.77K	1.35K	1.62K	218.00	192.00	48.00	191.00	N/A	N/A	13.63K	10.41K	2.90K	1.72K	5.80K	843.00	178.00	134.00	48.00	54.00
Diluted Shares Outstanding	102.70K	7.32K	3.77K	1.35K	1.62K	218.00	192.00	48.00	191.00	N/A	N/A	13.63K	10.41K	2.90K	1.72K	5.80K	843.00	178.00	134.00	48.00	54.00
EBITDA	-14.48M	-24.93M	-60.62M	-18.09M	-17.22M	-36.97M	-34.39M	-19.50M	-27.68M	-25.40M	-24.56M	-22.32M	-24.92M	-15.01M	-16.50M	-35.74M	-26.58M	-18.03M	-11.02M	-3.45M	-1.90M
EBITDA Margin	-166.92%	-221.75%	-445.71%	-160.15%	-114.15%	-6,092.70%	-2,671.86%	-2,479.47%	-9,478.53%	0.00%	0.00%	-7,154.48%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT	-11.34M	-46.48M	-61.21M	-19.76M	-74.65M	-84.59M	-36.13M	-15.29M	-27.12M	-25.25M	-23.98M	-22.79M	-24.53M	-15.29M	-20.53M	-33.59M	-26.38M	-17.41M	-10.97M	N/A	N/A
EBIT Margin	-130.62%	-413.53%	-450.05%	-174.90%	-494.72%	-13,941.74%	-2,806.87%	-1,943.97%	-9,286.45%	0.00%	0.00%	-7,302.93%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31